These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1397778)

  • 1. The effects of sympathetic nervous system activation and psychological stress on glucose metabolism and blood pressure in subjects with type 2 (non-insulin-dependent) diabetes mellitus.
    Bruce DG; Chisholm DJ; Storlien LH; Kraegen EW; Smythe GA
    Diabetologia; 1992 Sep; 35(9):835-43. PubMed ID: 1397778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM.
    Tack CJ; Smits P; Willemsen JJ; Lenders JW; Thien T; Lutterman JA
    Diabetes; 1996 Jan; 45(1):15-22. PubMed ID: 8522054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects.
    Schumann U; Jenkinson CP; Alt A; Zügel M; Steinacker JM; Flechtner-Mors M
    PLoS One; 2017; 12(3):e0173803. PubMed ID: 28346464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
    Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
    Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy.
    Porcellati F; Fanelli C; Bottini P; Epifano L; Rambotti AM; Lalli C; Pampanelli S; Scionti L; Santeusanio F; Brunetti P
    Diabetes; 1993 Jul; 42(7):1055-64. PubMed ID: 8513972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of age on insulin stimulation of sympathetic nervous system activity in man.
    Minaker KL; Rowe JW; Young JB; Sparrow D; Pallotta JA; Landsberg L
    Metabolism; 1982 Dec; 31(12):1181-4. PubMed ID: 6755163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal regulation of sympathetic nervous activity and heart rate after oral glucose in type 1 (insulin-dependent) diabetic patients.
    Hegedüs L; Christensen NJ; Sestoft L
    Diabetologia; 1983 Sep; 25(3):242-6. PubMed ID: 6642090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS; Elliott T
    Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.
    Torlone E; Rambotti AM; Perriello G; Botta G; Santeusanio F; Brunetti P; Bolli GB
    Diabetologia; 1991 Feb; 34(2):119-25. PubMed ID: 2065846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance.
    Capaldo B; Napoli R; Di Marino L; Picardi A; Riccardi G; Sacca L
    J Clin Endocrinol Metab; 1988 Nov; 67(5):893-8. PubMed ID: 3053749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of regulation by sympathetic hepatic nerves of liver metabolism and haemodynamics in chronically streptozotocin-diabetic rats.
    Stümpel F; Kucera T; Bazotte R; Püschel GP
    Diabetologia; 1996 Feb; 39(2):161-5. PubMed ID: 8635667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.
    Golay A; DeFronzo RA; Ferrannini E; Simonson DC; Thorin D; Acheson K; Thiébaud D; Curchod B; Jéquier E; Felber JP
    Diabetologia; 1988 Aug; 31(8):585-91. PubMed ID: 3065112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats.
    Rafiq K; Fujisawa Y; Sherajee SJ; Rahman A; Sufiun A; Kobori H; Koepsell H; Mogi M; Horiuchi M; Nishiyama A
    Diabetologia; 2015 Dec; 58(12):2885-98. PubMed ID: 26450431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
    Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
    Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans.
    Florian JP; Pawelczyk JA
    Clin Sci (Lond); 2009 Oct; 118(1):61-9. PubMed ID: 19426144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
    Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.
    García M; Morán A; Calama E; Martín ML; Barthelmebs M; Román LS
    Br J Pharmacol; 2005 Jul; 145(5):593-601. PubMed ID: 15852039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.